Keywords: پاسخ کامل پاتولوژیک; Pathologic complete response; Neoadjuvant chemoradiotherapy; Locally advanced rectal cancer; Leukocyte/lymphocyte ratio; Platelet/lymphocyte ratio;
مقالات ISI پاسخ کامل پاتولوژیک (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: پاسخ کامل پاتولوژیک; Esophagogastric adenocarcinoma; Pathologic complete response; Pre-operative; Histology;
Keywords: پاسخ کامل پاتولوژیک; Neoadjuvant chemoradiotherapy; Interval; Pathologic complete response; Esophageal cancer; Surgery;
Keywords: پاسخ کامل پاتولوژیک; BC; breast cancer; LAR; Luminal Androgen receptor; BL1; Basal Like 1; BL2; Basal Like 2; MSL; Mesenchymal Stem-Like; M; mesenchymal; IM; immunomodulatory; UNS; unstable; HR; homologous recombination; pCR; pathologic complete response; ORR; Objective Respo
Keywords: پاسخ کامل پاتولوژیک; Body mass index; Circulating tumor cells; Inflammatory breast cancer; Obesity; Pathologic complete response; Prognosis;
Keywords: پاسخ کامل پاتولوژیک; CRT; chemoradiotherapy; FEV1; forced expiratory volume in 1 second; JCOG; Japan Clinical Oncology Group; OS; overall survival; pCR; pathologic complete response; PS; performance status; SST; superior sulcus tumor; SWOG; Southwestern Oncology Group;
Keywords: پاسخ کامل پاتولوژیک; Optical mammography; near-infrared spectroscopy; breast cancer; neoadjuvant therapy; [Hb]; concentration of deoxyhemoglobin; [HbO2]; concentration of oxyhemoglobin; [HbT]; concentration of total hemoglobin; CRI; cumulative response index; Hgb; hemoglobin
Keywords: پاسخ کامل پاتولوژیک; Breast cancer; MRI; Neoadjuvant chemotherapy; Axillary lymph node dissection; Pathologic complete response
Keywords: پاسخ کامل پاتولوژیک; EC; esophageal cancer; 5-FU; 5-fluorouracil; GAC; gastric adenocarcinoma; GC; gastric cancer; GEAC; gastric and gastroesophageal adenocarcinomas; HR; hazard ratio; LN; lymph node; OS; overall survival; pathCR; pathologic complete response; PET; positron e
Keywords: پاسخ کامل پاتولوژیک; aRR; adjusted risk ratio; AUC; area under the receiver operating curve; NCCN; National Comprehensive Cancer Network; NCDB; National Cancer Data Base; pCR; pathologic complete response;
Keywords: پاسخ کامل پاتولوژیک; Breast cancer; Immune system; Biomarkers; Immunotherapies; Immune checkpoint blockade; Tumor vaccines; ADCC; antibody dependent cellular cytotoxicity; BiTES; bispecific single chain monoclonal antibodies; CAR; T cells engineered to express artificial chim
Keywords: پاسخ کامل پاتولوژیک; CT; computed tomography; LOS; length of stay; MRI; magnetic resonance imaging; NSCLC; non-small cell lung cancer; pCR; pathologic complete response; PET/CT; integrated positron emission tomography with computed tomography; pNR; pathologic nearly complete
Keywords: پاسخ کامل پاتولوژیک; Locally advanced rectal cancer; Boost radiation; Pathologic complete response; Systematic review; Meta-analysis;
Role of 18F-PET/CT in Predicting Prognosis of Patients With Breast Cancer After Neoadjuvant Chemotherapy
Keywords: پاسخ کامل پاتولوژیک; Chemotherapeutic drugs; Imaging; Malignant tumors; Pathologic complete response;
Evaluation of Immune Reaction and PD-L1 Expression Using Multiplex Immunohistochemistry in HER2-Positive Breast Cancer: The Association With Response to Anti-HER2 Neoadjuvant Therapy
Keywords: پاسخ کامل پاتولوژیک; Breast carcinoma; Cytotoxic T-cells; Immune checkpoint system; Pathologic complete response; Tumor-associated lymphocytes;
Neutrophil to Lymphocyte Ratio as Predictor of Treatment Response in Esophageal Squamous Cell Cancer
Keywords: پاسخ کامل پاتولوژیک; cCR; clinical complete response; ÎNLR; difference in neutrophil to lymphocyte ratio; DFS; disease-free survival; ESCC; esophageal squamous cell carcinoma; IQR; interquartile range; NLR; neutrophil to lymphocyte ratio; pCR; pathologic complete response; Q
Optimal Interval to Surgery After Neoadjuvant Chemoradiotherapy in Rectal Cancer: AÂ Systematic Review and Meta-analysis
Keywords: پاسخ کامل پاتولوژیک; Neoadjuvant chemoradiotherapy; Pathologic complete response; Rectal cancer; Surgery; Waiting interval;
Identifying pathologic complete response of the breast after neoadjuvant systemic therapy with ultrasound guided biopsy to eventually omit surgery: Study design and feasibility of the MICRA trial (Minimally Invasive Complete Response Assessment)
Keywords: پاسخ کامل پاتولوژیک; Breast cancer; Neoadjuvant systemic therapy; Pathologic complete response; Minimally invasive; Response prediction;
The Prognostic Effect of Changes in Tumor Stage and Nodal Status After Neoadjuvant Chemotherapy in Each Primary Breast Cancer Subtype
Keywords: پاسخ کامل پاتولوژیک; Epidermal growth factor receptor-2; Hormone receptor; Neoadjuvant chemotherapy; Nuclear grade; Pathologic complete response;
Use of sequential endorectal US to predict the tumor response of preoperative chemoradiotherapy in rectal cancer
Keywords: پاسخ کامل پاتولوژیک; AUC; area under the curve; CRT; chemoradiotherapy; ERUS; endorectal ultrasonography; MRI; magnetic resonance imaging; pCR; pathologic complete response; ROC; receiver-operating characteristic; TME; total mesorectal excision; TRG; tumor regression grade;
Specific gene expression profiles are associated with a pathologic complete response to neoadjuvant therapy in esophageal adenocarcinoma
Keywords: پاسخ کامل پاتولوژیک; Esophageal cancer; Biomarker; Pathologic complete response; Neoadjuvant therapy; Gene expression;
Radiomics predicts clinical outcome in primary gastroesophageal junction adenocarcinoma treated by chemo/radiotherapy and surgery
Keywords: پاسخ کامل پاتولوژیک; Radiomics; Gastroesophageal junction adenocarcinoma; Survival; Pathologic complete response; Prognostic model; Texture analysis; Radiology;
Anthracycline-Free Neoadjuvant Chemotherapy Ensures Higher Rates of Pathologic Complete Response in Breast Cancer
Keywords: پاسخ کامل پاتولوژیک; Carboplatin; Pathologic complete response; Survival; Taxane; Toxicity;
Prognostic Effect of Carcinoma In Situ in Muscle-invasive Urothelial Carcinoma Patients Receiving Neoadjuvant Chemotherapy
Keywords: پاسخ کامل پاتولوژیک; CIS; NAC; Pathologic complete response; Transurethral resection of bladder tumor; UC;
Comparison of 5-FU-based and Capecitabine-based Neoadjuvant Chemoradiotherapy in Patients With Rectal Cancer: A Meta-analysis
Keywords: پاسخ کامل پاتولوژیک; Capecitabine; 5-fluorouracil; Pathologic complete response; Rectal cancer; Tumor down-staging;
MRI and Prediction of Pathologic Complete Response in the Breast and Axilla after Neoadjuvant Chemotherapy for Breast Cancer
Keywords: پاسخ کامل پاتولوژیک; ALN; axillary lymph node; ER; estrogen receptor; HER2; human epidermal growth factor receptor 2; LN; lymph node; NAC; neoadjuvant chemotherapy; NPV; negative predictive value; pCR; pathologic complete response; PPV; positive predictive value; PR; progeste
Long-term outcomes in ypT0 rectal cancers: An international multi-centric investigation on behalf of Italian Society of Surgical Oncology Young Board (YSICO)
Keywords: پاسخ کامل پاتولوژیک; Rectal cancer; Neo-adjuvant treatment; Pathologic complete response; ypT0;
Survival Impact of Adjuvant Chemotherapy for Resected Locally Advanced Rectal Adenocarcinoma
Keywords: پاسخ کامل پاتولوژیک; Overall survival; Pathologic complete response; Postoperative chemotherapy; Preoperative chemoradiotherapy; Surgery;
EUS-guided paclitaxel injection as an adjunctive therapy to systemic chemotherapy and concurrent external beam radiation before surgery for localized or locoregional esophageal cancer: a multicenter prospective randomized trial
Keywords: پاسخ کامل پاتولوژیک; 5-FU; 5-fluorouracil; AE; adverse event; CI; confidence interval; CR; complete response; CRT; chemoradiotherapy; DLT; dose-limiting toxicity; ECOG; Eastern Cooperative Oncology Group; KPS; Karnofsky Performance Status; mITT; modified intention to treat; m
Tumor-infiltrating lymphocytes in patients with HER2-positive breast cancer treated with neoadjuvant chemotherapy plus trastuzumab, lapatinib or their combination: A meta-analysis of randomized controlled trials
Keywords: پاسخ کامل پاتولوژیک; Tumor-infiltrating lymphocytes; Neoadjuvant treatment; HER2-postive breast cancer; Pathologic complete response; Trastuzumab; Lapatinib;
Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival in advanced stage ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study
Keywords: پاسخ کامل پاتولوژیک; Pathologic complete response; Secondary cytoreduction;
Étude de réponse histologique du cancer du sein HER2+ après chimiothérapie néoadjuvante associant taxane et trastuzumab
Keywords: پاسخ کامل پاتولوژیک; Cancer du sein; Chimiothérapie néoadjuvante; Trastuzumab; Réponse histologique complèteBreast cancer; Neoadjuvant chemotherapy; Trastuzumab; Pathologic complete response
Utility of the CPSÂ +Â EG staging system in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer treated with neoadjuvant chemotherapy
Keywords: پاسخ کامل پاتولوژیک; CPSÂ +Â EG score; Hormone-receptor positive; HER2 negative; Breast cancer; Prognosis; Neoadjuvant chemotherapy; Pathologic complete response;
Proliferation Determined by Ki-67 Defines Different Pathologic Response to Neoadjuvant Trastuzumab-Based Chemotherapy in HER2-Positive Breast Cancer
Keywords: پاسخ کامل پاتولوژیک; HER2-positive breast cancer; Ki-67 marker; Neoadjuvant trastuzumab-based chemotherapy; Pathologic complete response; Predictive factor
Phase II Study of Neoadjuvant Anthracycline-Based Regimens Combined With Nanoparticle Albumin-Bound Paclitaxel and Trastuzumab for Human Epidermal Growth Factor Receptor 2-Positive Operable Breast Cancer
Keywords: پاسخ کامل پاتولوژیک; Human epidermal growth factor receptor 2; Nanoparticle albumin-bound paclitaxel; Neoadjuvant chemotherapy; Pathologic complete response; Trastuzumab
Outcomes of Hispanic women with lymph-node positive, HER2 positive breast cancer treated with neoadjuvant chemotherapy and trastuzumab in Mexico
Keywords: پاسخ کامل پاتولوژیک; Breast cancer; Trastiuzumab; Neoadjuvant therapy; Receptor, erbB-2; Latin America; Hispanics; HR; hormone receptor; RFS; recurrence-free survival; OS; overall survival; pCR; pathologic complete response; INCan; National Cancer Institute of Mexico; ER; est
Analysis of fiducials implanted during EUS for patients with localized rectal cancer receiving high-dose rate endorectal brachytherapy
Keywords: پاسخ کامل پاتولوژیک; 5-FU; 5-fluorouracil; HDR-EBT; high-dose rate endorectal brachytherapy; IQR; interquartile range; MRI; magnetic resonance imaging; pCR; pathologic complete response; RT; radiation therapy; TF; traditional fiducial; XMF; X-mark fiducial;
High Pathologic Complete Response in Her2-Positive, Early-Stage Breast Cancer to a Novel Nonanthracycline Neoadjuvant Chemotherapy
Keywords: پاسخ کامل پاتولوژیک; Breast cancer; Nab-paclitaxel; Neoadjuvant chemotherapy; Pathologic complete response; Trastuzumab;
Original StudyLong-Term Follow-Up After Preoperative Trastuzumab and Chemotherapy for HER2-Overexpressing Breast Cancer
Keywords: پاسخ کامل پاتولوژیک; Anthracycline; Cardiotoxicity; Neoadjuvant therapy; Pathologic complete response;
Postoperative CMF Does Not Ameliorate Poor Outcomes in Women With Residual Invasive Breast Cancer After Neoadjuvant Epirubicin/Docetaxel Chemotherapy
Keywords: پاسخ کامل پاتولوژیک; CMF; Neoadjuvant chemotherapy; Pathologic complete response; Postneoadjuvant chemotherapy; Survival;
Neoadjuvant chemoradiotherapy with cisplatin plus vinorelbine versus cisplatin plus fluorouracil for esophageal squamous cell carcinoma: A matched case-control study
Keywords: پاسخ کامل پاتولوژیک; Esophageal cancer; Pathologic complete response; Neoadjuvant chemoradiotherapy; Survival; Toxicity;
Original scientific articleExtended Intervals after Neoadjuvant Therapy in Locally Advanced Rectal Cancer: The Key to Improved Tumor Response and Potential Organ Preservation
Keywords: پاسخ کامل پاتولوژیک; NCDB; National Cancer Data Base; nCRT; neoadjuvant chemoradiotherapy; OR; odds ratio; pCR; pathologic complete response;
Can pathologic complete response (pCR) be used as a surrogate marker of survival after neoadjuvant therapy for breast cancer?
Keywords: پاسخ کامل پاتولوژیک; Pathologic complete response; Neoadjuvant chemotherapy; Surrogate marker; Breast cancer sugroups
Pathologic complete response after neoadjuvant chemotherapy in HER2-overexpressing breast cancer according to hormonal receptor status
Keywords: پاسخ کامل پاتولوژیک; Pathologic complete response; HER2; Hormonal receptor; Trastuzumab; Neoadjuvant chemotherapy; Breast cancer;
Phase II Trial of Neoadjuvant Weekly Nanoparticle Albumin-Bound Paclitaxel, Carboplatin, and Biweekly Bevacizumab Therapy in Women With Clinical Stage II or III HER2-Negative Breast Cancer
Keywords: پاسخ کامل پاتولوژیک; Carboplatin; Human epidermal growth factor receptor–negative breast cancer; Nanoparticle albumin-bound paclitaxel; Neoadjuvant chemotherapy; Pathologic complete response
Neoadjuvant chemotherapy with sequential anthracycline-docetaxel with gemcitabine for large operable or locally advanced breast cancer: ANZ 0502 (NeoGem)
Keywords: پاسخ کامل پاتولوژیک; Locally advanced breast cancer; Neoadjuvant chemotherapy; Gemcitabine; Phase 2; Pathologic complete response;
Current and future role of neoadjuvant therapy for breast cancer
Keywords: پاسخ کامل پاتولوژیک; Breast cancer; Molecular subtypes; Neoadjuvant systemic therapy; Pathologic complete response; Breast conserving surgery;
Neoadjuvant Therapy in the Treatment of Breast Cancer
Keywords: پاسخ کامل پاتولوژیک; Breast cancer; Neoadjuvant chemotherapy; Preoperative chemotherapy; Pathologic complete response;
Phase II study of liposome-encapsulated doxorubicin plus cyclophosphamide, followed by sequential trastuzumab plus docetaxel as primary systemic therapy for breast cancer patients with HER2 overexpression or amplification
Keywords: پاسخ کامل پاتولوژیک; Breast cancer; Neoadjuvant chemotherapy; Liposomal anthracycline; Trastuzumab; Pathologic complete response; HER-2 positive;
Accelerated hyperfractionated radiotherapy within trimodality therapy concepts for stage IIIA/B non-small cell lung cancer: Markedly higher rate of pathologic complete remissions than with conventional fractionation
Keywords: پاسخ کامل پاتولوژیک; Accelerated-hyperfractionation; Pathologic complete response; Trimodality; Stage III NSCLC; Radiochemotherapy;